![Bayer Adempas (riociguat) Phase IV Study Is Successful: Strong Efficacy In Patients With Insufficient PDE5i Response! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd Bayer Adempas (riociguat) Phase IV Study Is Successful: Strong Efficacy In Patients With Insufficient PDE5i Response! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd](https://www.hsppharma.com/Content/uploads/2020524038/2020091511251502016bad5d534808bf56db324524e6ed.png)
Bayer Adempas (riociguat) Phase IV Study Is Successful: Strong Efficacy In Patients With Insufficient PDE5i Response! - Industry news - News - Hefei Home Sunshine Pharmaceutical Technology Co., Ltd
![Riociguat. Comprimido. Cada comprimido contiene: Riociguat 2.5 mg Envase con 42 comprimidos. - Heka – Insumos Medicos Riociguat. Comprimido. Cada comprimido contiene: Riociguat 2.5 mg Envase con 42 comprimidos. - Heka – Insumos Medicos](https://heka.mx/wp-content/uploads/2023/10/adempas-riociguat-42-comprimidos-bayer-600x600.jpg)
Riociguat. Comprimido. Cada comprimido contiene: Riociguat 2.5 mg Envase con 42 comprimidos. - Heka – Insumos Medicos
![These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS.ADEMPAS (riociguat) tablets, for oral useInitial U.S. Approval: 2013 These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS.ADEMPAS (riociguat) tablets, for oral useInitial U.S. Approval: 2013](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=e9e1a668-1b31-4094-88b7-2004f94af53d-12.jpg&id=691105)
These highlights do not include all the information needed to use ADEMPAS safely and effectively. See full prescribing information for ADEMPAS.ADEMPAS (riociguat) tablets, for oral useInitial U.S. Approval: 2013
![The U.S. Food and Drug Administration approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. | New Drug Approvals The U.S. Food and Drug Administration approved Adempas (riociguat) to treat adults with two forms of pulmonary hypertension. | New Drug Approvals](https://i0.wp.com/upload.wikimedia.org/wikipedia/commons/thumb/6/68/Riociguat_structure.svg/160px-Riociguat_structure.svg.png)